CombiCTx: Screening diffusion gradients of anti-cancer drug combinations
URL https://www.biorxiv.org/content/10.1101/2025.02.27.635465v1.full.pdf Stage Normal Science Paradigm framing The preprint operates within the dominant paradigm of in vitro cancer drug screening, specifically focusing on combination therapies. It adheres to the established methodology of evaluating drug efficacy and interactions, employing well-established techniques like microscopy and cell viability assays. Highlights This preprint presents a refinement of existing drug […]
CombiCTx: Screening diffusion gradients of anti-cancer drug combinations Read More »